SuperworthTvardi Therapeutics shares outstanding TVRD
Diluted shares outstanding, averaged over each quarter, from 2013.
- Latest quarter, to Jun 30, 2026
- 9.4M
- On a year earlier
- +11.0%
- more shares
Tvardi Therapeutics had 9.4M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 11.0% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 18.1M | +206% |
| FY2024 | 5.9M | +291% |
| FY2023 | 1.5M | +1% |
| FY2022 | 1.5M | +2% |
| FY2021 | 1.5M | +6% |
| FY2020 | 1.4M | +7% |
| FY2019 | 1.3M | +18% |
| FY2018 | 1.1M | +21% |
| FY2017 | 905.7K | +19% |
| FY2016 | 758.1K | +0% |
| FY2015 | 756.7K | +20% |
| FY2014 | 633.1K | +431% |
| FY2013 | 119.1K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 9.4M | +11% | |
| Q1 FY26 | 9.4M | +264% | |
| Q4 FY25 | 18.1M | +206% | |
| Q3 FY25 | 9.4M | +264% | |
| Q2 FY25 | 8.5M | +228% | |
| Q1 FY25 | 2.6M | +70% | |
| Q4 FY24 | 5.9M | +291% | |
| Q3 FY24 | 2.6M | +71% | |
| Q2 FY24 | 2.6M | +72% | |
| Q1 FY24 | 1.5M | +1% | |
| Q4 FY23 | 1.5M | +1% | |
| Q3 FY23 | 1.5M | +1% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Tvardi Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.